"Sun Pharma"
Latest news and video coverage curated from trusted media outlets
0 shares | ShareTweetSavePostSend |
You Might Like
India's Sun Pharma launches anti-baldness drug Leqselvi in USUpworthy - Published | |
Sun Pharma, Mankind, Cipla Lead Recruitments at SGT University's Mega Job Fest: PharmaPICK 2.0![]() NewsVoir - Published | |
Torrent Pharma becomes India’s 5th largest drugmakerTorrent Pharma's acquisition of JB Chemicals & Pharmaceuticals propels it to become India's fifth-largest pharmaceutical company, capturing a 4.6% market share. This deal significantly strengthens..IndiaTimes - Published | |
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspectionSun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13,..IndiaTimes - Published | |
Sun Pharma elevates Kirti Ganorkar as MD; Dilip Shanghvi to stay on as exec chairmanSun Pharma's India business head, Kirti Ganorkar, will become the managing director on September 1, succeeding founder Dilip Shanghvi. Shanghvi will transition to executive chairman, while his son..IndiaTimes - Published | |
Stock Market Today: Sensex Surges Over 2,100 Pts, Nifty Above 24,650Stock Market Today: In the Sensex pack, Adani Ports, Bajaj Finance, Axis Bank, Eternal, Power Grid, NTPC, Bajaj Finserv, Tata Steel, L&T, SBI were the top gainers. Whereas, only Sun Pharma was the top..Zee News - Published | |
Glenmark, Sun Pharma, Zydus recall medicines in US over manufacturing issuesnewKerala.com - Published | |
US court clears way for Sun Pharma to launch autoimmune disorder drugnewKerala.com - Published | |
Indian pharma stocks tumble as Trump signals tariffs on drug importsIndian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like..IndiaTimes - Published | |
Sensex, Nifty Extend Gains For 3rd Straight Session, Midcap Stocks OutperformStock Market Highlights: On the other hand, Tech Mahindra, Britannia, TCS, Infosys, and Sun Pharma were among the 17 stocks that declined, with losses of up to 2.32 per cent.Zee News - Published | |
Sun Pharma to acquire US oncology compony for over Rs 3,000 croreSun Pharma, India's largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma's specialty portfolio, including..IndiaTimes - Published | |
Sun Pharma, Reliance Industries: Top stock recommendations for todayIndiaTimes - Published | |
Sensex, Nifty Open Marginally Higher Amidst Cautious Market SentimentAmong the top gainers were Wipro, Infosys, Sun Pharma, TCS, and ITC. Conversely, BEL, Tata Motors, Power Grid, Adani Enterprises, and HDFC Life emerged as the top losersZee News - Published | Sensex jumps over 1,400 pts, best day in nearly 2 monthsThe sensex surged by 1,436 points, nearly reaching 80,000, driven by broad-based buying and short covering. Gains in banking, IT, auto and metal stocks also fuelled the rally amidst low foreign fund..IndiaTimes - Published |
Meet one of richest man in India, who is leading health sector in nation, not Mukesh Ambani, Gautam Adani, he is...As the chairman and managing director of Sun Pharma, Dilip Shanghvi started his venture in 1983 with a mere $200 borrowed from his father, initially concentrating on the production of psychiatric..DNA - Published | Sun Pharma profit up 28% on higher salesIndiaTimes - Published |
Indian Foundation for Quality Management (IFQM) Calls for Shared Partnerships to Achieve Quality Processes in the Industry![]() NewsVoir - Published | Captains of the Industry, Global Quality Experts, Academia and Policy Makers Come Together for the First, 2-day, IFQM Symposium, on Oct 15-16, 2024The Indian Foundation for Quality Management (IFQM), setup by a consortium of leading Indian companies', seeks to catalyse transformational changes centred on Quality, Excellence and Innovation. IFQM..NewsVoir - Published |
Sensex hits record high at 85,955 as Nifty gains, large caps outpace mid and small capsOn Friday, Indian equity benchmark indices BSE Sensex and Nifty50 maintained their upward momentum. Infosys, TCS, and Sun Pharma emerged as top gainers. Meanwhile, financial indices such as Nifty Bank..IndiaTimes - Published | Sensex Trades Higher After Opening At New All-Time HighIn the Sensex pack, Bajaj Finance, Bajaj Finserv, HDFC Bank, NTPC, Power Grid, L&T, Titan, M&M, Asian Paints and Reliance are the top gainers. Tata Motors, Tech Mahindra, Wipro, TCS, Sun Pharma and HCL..Zee News - Published |
Sensex Rebounds 1,293 Pts, Nifty Ends At Record High On Value Buying After 5 Days Of LossesBharti Airtel was the biggest gainer, rising by over 4.51 per cent. Adani Ports, Sun Pharma, Tata Steel, HCL Technologies, Infosys, JSW Steel and Mahindra & Mahindra were the other big gainers.Zee News - Published | SC upholds NPPA's Rs 4.6 crore penalty on Sun PharmaSun Pharmaceutical Industries Ltd, the sixth-largest generic pharmaceutical manufacturer in the world, had questioned NPPA's demand notice of 2005 for payment of Rs 4.6 crore "to recover the higher..IndiaTimes - Published |
Sun Pharma completes Taro merger in a deal valued at $348 millionIndiaTimes - Published | Top Stocks On D-Street: Sun Pharma, Hindustan Zinc, Bajaj Consumer Among 7 Stocks Lead Today's Market FocusRailTel Corporation shares surged nearly 10 per cent, closing at Rs 476.20, driven by a significant increase in trading volume.Zee News - Published |
Sensex, Nifty Settle Almost Flat Amid Volatile TradeAmong the 30 Sensex companies, Kotak Mahindra Bank, Asian Paints, Reliance Industries, ITC, Sun Pharma, ICICI Bank, Axis Bank and JSW Steel were the major laggards.Zee News - Published | Markets Hit All-Time High Amid Strong FII ComebackOn the other hand, Indigo, Zydus Lifesciences, Bajaj Holdings, Sun Pharma, Nykaa, and Zomato were the major laggards.Zee News - Published |
Sensex Slumps 600 Points As Heavyweight Stocks Sold OffSensex constituents which are dragging the benchmark include Sun Pharma down 3.5 per cent.Zee News - Published | Stock Markets Rise For 3rd Session; Sensex Gains 190 PointsFrom the Sensex basket, Sun Pharma, Maruti, IndusInd Bank, Titan, ITC, Tata Motors, Larsen & Toubro and JSW Steel were the major gainers.Zee News - Published |
India Takes Aim at Global Competitiveness with the Launch of World Class Quality Institute - India Foundation for Quality Management (IFQM)In a bold move to address a critical challenge, a consortium of seven leading Indian companies have launched the *Indian Foundation for Quality Management (IFQM)*, a Section 8 not-for-profit Company...NewsVoir - Published | Sensex, Nifty reach new all-time high levels on gains in banking, IT sharesThe stock market ended on a positive note with the Sensex and Nifty reaching fresh record highs. Gains in the European markets helped in recovery. Top gainers included Kotak Mahindra Bank, Axis Bank,..IndiaTimes - Published |
Nifty Snaps Two-Day Decline In Choppy Trading SessionDefensive sectors like IT and pharma were in momentum with key gainers in large caps like TCS, Sun Pharma, and Cipla.Zee News - Published | Sun Pharma Q3 net profit rises 16.5 per cent to Rs 2,523.8 croreSun Pharmaceutical Industries Ltd reports 16.52% rise in Q3 net profit to Rs 2,523.8 crore. Consolidated total revenue from operations stood at Rs 12,380.7 crore. The company declares interim dividend..IndiaTimes - Published |
Pharma, Healthcare Stocks Top Sectoral Gainers In TradeSun Pharma is the top Sensex gainer with gains of more than 3 per cent. Dr Reddy's is up more than 4 per cent. Max Healthcare is up 6 per cent.Zee News - Published | Sun Pharma to acquire remaining stake in subsidiary Taro for $348 millionSun Pharma has announced its intention to acquire the remaining shares of its Israeli subsidiary, Taro Pharma, at a rate of $43 per share, totaling approximately $348 million. This acquisition cost..IndiaTimes - Published |
Sun Pharma & Bayer tie up to market new renal therapySun Pharma and Bayer have entered into an agreement to market and distribute a second brand of the patented medicine Finerenone in India. Finerenone is designed to reduce the risk of various..IndiaTimes - Published | This man visited shops to sell medicines, started business with Rs 2000, now runs Rs 260000 crore firm, net worth is...In 1982, he borrowed Rs 2000 from his father and, along with his friends, started his pharmaceutical company Sun Pharma in Gujarat's Vapi.DNA - Published |
Pharma faces USFDA heat, stocks downThe stocks of several pharma companies, including Dr Reddy's, Aurobindo Pharma, Cipla, Lupin, Sun Pharma, and Divi's Labs, have been lagging behind as the sensex and Nifty reach new highs. Dr Reddy's..IndiaTimes - Published | Markets climb in early trade on buying in RelianceThe 30-share BSE Sensex climbed 74.43 points to 66,005.20 in early trade. The Nifty went up by 26.15 points to 19,809.55. Among the Sensex firms, Power Grid, Titan, Sun Pharma, Reliance Industries,..IndiaTimes - Published |
Stock markets recover after 2-day decline; banking, metal shares shineThe 30-share BSE Sensex climbed 275.62 points or 0.42 per cent to settle at 65,930.77. During the day, it jumped 427.21 points or 0.65 per cent to 66,082.36. The broader Nifty went up by 89.40 points..IndiaTimes - Published | Markets decline in early trade after 3 days of rallyThe 30-share BSE Sensex declined 216.73 points to 64,741.96. The Nifty slipped 63.05 points to 19,348.70. Among the Sensex firms, ICICI Bank, Power Grid, HDFC Bank, Bharti Airtel, Asian Paints and..IndiaTimes - Published |
Equity benchmarks stay on upward track for 2nd day on positive global trendsEquity benchmark indices, Sensex and Nifty, continued their upward movement for the second consecutive day, closing with gains on Friday. The Sensex rose by 0.44% to settle at 64,363.78, while the..IndiaTimes - Published | Sun Pharma reports strong quarter 2 salesSun Pharma reported an increase of 11% in gross sales to Rs 12,031 crore with a 5% jump in net profit to Rs 2,375.5 crore for the second quarter ended September. India formulation sales were up by 11%..IndiaTimes - Published |
Sun Pharma posts Rs 2,375.5 crore Quarter 2 net profitSun Pharmaceuticals reported a 5% increase in its consolidated net profit for the second quarter of FY 2024. The company's revenue also rose by 11.3% and its EBITDA came in at Rs 3,179 crore. Sun..IndiaTimes - Published | Sun Pharma, Zydus to co-market drug for CKD-induced anaemiaLeading Indian drugmakers, Zydus Lifesciences and Sun Pharmaceutical industries entered into a licensing agreement to co-market Desidustat, an oral treatment for anaemia, associated with chronic kidney..IndiaTimes - Published |
Red opening marks a challenging start for Indian stock market amidst global headwindsThe stock market in India opened in the red and slipped into negative territory due to global headwinds and geopolitical tensions. Bajaj Auto, Mindtree, Hero Motocorp, Nestle India, and Ultra Cement..IndiaTimes - Published | Stock markets rebound on positive trend in Asian, European equitiesThe 30-share BSE Sensex rose by 173.22 points or 0.26 per cent to settle at 66,118.69. The Nifty gained 51.75 points or 0.26 per cent to end at 19,716.45. Among the Sensex firms, Larsen & Toubro, ITC,..IndiaTimes - Published |
Sensex Climbs 152.12 Points To Settle At 65,780New Delhi: Equity benchmark indices Sensex and Nifty closed higher for the third straight day on Tuesday on gains in market heavyweights ITC, Reliance Industries and Infosys amid a bearish trend in..Zee News - Published | #TheBigMove of Tech Mahindra Global Chess League Redefines Chess Branding, Makes it to Ads Of The WorldThe Tech Mahindra Global Chess League (GCL) is making waves, not just in the world of chess but also in advertising with its groundbreaking #TheBigMove campaign. The campaigns immense impact has now..NewsVoir - Published |
Sun Pharma to acquire Taro's 100% stake in all-cashIn the all cash deal, Sun Pharma will acquire the shares at a price of US $38 per ordinary share, which will be payable in full at the close of the proposed transaction, the company said in a BSE..IndiaTimes - Published | India's Sun Pharma Posts Near-30% Rise In Q4 Profit On Lower Input CostsShares of Sun Pharma settled 2.6 percent higher after the results and snapped six weeks of losses with a gain of 4.8 percent for the week.Zee News - Published |